PGEN Precigen Inc Total Asset Value of Company
The Precigen, Inc. (PGEN) total asset price chart is fixed at 290.56. Precigen, Inc. (PGEN) operates in an underserved gene therapy segment, collaborating with medical centers. Growth is driven by UltraVector platform innovations and expectations surrounding the PRGN-2012 vaccine. AI-driven design and synthesis automation are accelerating processes, although final drug verification remains the responsibility of the expert community of physicians and scientists.
Analytical breakdowns and data insights for company Intrexon (PGEN)
- stock quotes and analyst forecast:
- market capitalization data:
- issuer book value statistics:
- debt burden and liquidity indicators:
Fundamental valuation:Precigen, Inc.
The scale of Precigen, Inc. (PGEN) operations in developing gene-programmable therapies and advancing the UltraVector platform determines the resource volume captured in the value 290.56. This metric, reverse-calculated via ROA, measures the aggregate of all controlled assets and liabilities, allowing investors to distinguish real growth in technological potential from short-term market volatility through gross asset dynamics.
Key competitors
Total Business Assets ARGX|Aggregate Company Assets BioNTech|Abivax - Total Asset Value of Company|Company Total Assets ADMA|PTGX (Protagonist Corp) - Aggregate Asset Value|Company Total Assets IMVT (Immunovant, Inc.)|Company Total Assets kiniksa.com KNSA|GRFS - Aggregate Company Assets|Aggregate Asset Value ADPT (Adaptive Biotech)|Celldex (CLDX) - Aggregate Company Assets|Cumulative Company Assets Aurinia Corp|BCRX (BioCryst) - Company Total Assets|Company Total Assets veratx.com|Cumulative Company Assets DNTH (Dianthus Therapeutics, Inc.)|PHVS (Pharvaris NV) - Aggregate Asset Value|Company Total Assets ABCL (abcellera.com)|Company Total Asset Base Tourmaline (TRML)|PHAR - Aggregate Company Assets|nektar.com (NKTR) - Cumulative Company Assets|Upstream Bio (UPB) - Aggregate Company Assets|Cumulative Company Assets Zenas Bio|Cumulative Company Assets IMNM|Company Total Assets Gossamer Bio Corp.|Aggregate Company Assets KalVista Pharmaceuticals (KALV)|septerna.com - Total Business Assets|Company Total Assets PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Company Assets|RIGL - Aggregate Company Assets|Total Asset Value of Company ANAB|Astria Therapeutics (ATXS) - Aggregate Company Assets|engene.com - Aggregate Asset Value|RAPT (RAPT Therapeutics) - Company Total Assets|Company Assets Aerovate JBIO|Company Total Assets ACRS|Cumulative Company Assets Kyverna Therapeutics, Inc KYTX|Company Total Assets TLSA (Tiziana Life Sciences)|Company Total Asset Base cabalettabio.com (CABA)|Ventyx Biosciences, Inc. - Company Total Assets|Company Balance Sheet Assets Theratechnologies, Inc. (THTX)|AVTX: Company Total Assets|Company Assets Eledon Pharmaceuticals, Inc (ELDN)|Aggregate Company Assets Agenus|Total Business Assets CLYM (climbbio.com)|Cumulative Company Assets ZURA (Zura Bio)|ATYR (aTyr Pharma Inc) - Aggregate Asset Value|Company Total Assets ADAG (Adagene Inc.)|Company Total Asset Base ImageneBio (IMA)|STTK - Aggregate Company Assets|EQ (Equillium, Inc.) - Total Business Assets|CNTB: Company Total Assets|Cumulative Company Assets Immunic|Cumulative Company Assets ATRA|InflaRx GmbH (IFRX) - Company Total Asset Base|Aggregate Company Assets X4 Pharmaceuticals (XFOR)|ACET: Total Asset Value of Company|Company Total Assets CELU (Celularity)|Company Balance Sheet Assets INmune Bio Inc|Barinthus Bio - Company Total Assets|Company Assets Kezar Life Sciences Inc|SAB Biotherapeutics (SABS) - Aggregate Company Assets|Total Business Assets AKTX|Aggregate Company Assets Enlivex Therapeutics Ltd|Q32 Bio Corp - Total Asset Value of Company|Company Total Assets GOVX|EDSA (Edesa Biotech Corp) - Aggregate Asset Value|Company Total Assets IBIO (iBio, Inc.)|Company Total Assets Carisma Therapeutics Inc CARM|XTLB - Aggregate Company Assets|Aggregate Asset Value BOLT (Bolt Biotherapeutics)|hcwbiologics.com (HCWB) - Aggregate Company Assets|Cumulative Company Assets Aptevo Therapeutics Inc.|AIM (AIM ImmunoTech Inc.) - Company Total Assets|Company Total Assets Aditxt Corp|Cumulative Company Assets GRI (GRI Bio)|XRTX (XORTX Therapeutics Inc) - Aggregate Asset Value|Company Total Assets HIND (ReShape Lifesciences)|Company Total Asset Base Revelation Biosciences Corp (REVB)|INDP - Aggregate Company Assets|scinai.com (SCNI) - Cumulative Company Assets|calcimedica.com (CALI) - Aggregate Company Assets|Cumulative Company Assets Affimed N.V.|Cumulative Company Assets ALLK|Company Total Assets HOOKIPA|Aggregate Company Assets IGM Biosciences, Inc. (IGMS)|iteostherapeutics.com - Total Business Assets|Company Total Assets OCEA (Ocean Biomedical)|TC BioPharm (Holdings) Plc (TCBP) - Company Assets|THRD - Aggregate Company Assets